Literature DB >> 3115651

Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology.

V Malkovska1, J Murphy, L Hudson, D Bevan.   

Abstract

The functional and morphological changes induced by recombinant interleukin 2 (IL-2) were studied in purified B cells from patients with untreated B chronic lymphocytic leukaemia (B-CLL). In eight of nine patients, purified B-CLL cells increased their DNA synthesis in response to IL-2 without preactivation in vitro. This response, studied in detail in three patients, was dose dependent and reached a maximum on day 5 or 6. IL-2 induced or increased IgM secretion in cultures from five of the nine patients studied. Two of this responsive group were particularly interesting as IL-2 not only stimulated IgM secretion but also induced the secretion of IgG. Immunoglobulin production was invariably monoclonal. B CLL cells incubated with IL-2 showed distinct morphological changes including an increase in the size of cytoplasm and enlargement of nuclei together with the appearance of nucleoli. These changes were present in all IL-2 treated cultures but were more pronounced in those containing immunoglobulin secreting cells. None of the IL-2 induced changes appeared to correlate with the clinical stage of the disease or the level of Tac antigen expression on the freshly isolated CLL B cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115651      PMCID: PMC1542751     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Production of antibody by human B cells under serum-free conditions.

Authors:  J Farrant; C A Newton; M E North; C Weyman; M K Brenner
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

2.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.

Authors:  W J Leonard; J M Depper; T Uchiyama; K A Smith; T A Waldmann; W C Greene
Journal:  Nature       Date:  1982-11-18       Impact factor: 49.962

Review 3.  Molecular aspects of immunoglobulin expression by human B cell leukemias and lymphomas.

Authors:  J Gordon
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

4.  High incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients.

Authors:  M J Deegan; J P Abraham; M Sawdyk; E J Van Slyck
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

5.  Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells.

Authors:  M C Mingari; F Gerosa; G Carra; R S Accolla; A Moretta; R H Zubler; T A Waldmann; L Moretta
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

6.  Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate.

Authors:  M Malkovský; P B Medawar; D R Thatcher; J Toy; R Hunt; L S Rayfield; C Doré
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Expression of Tac antigen on activated normal human B cells.

Authors:  M Tsudo; T Uchiyama; H Uchino
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

8.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

9.  Interleukin 2-induced proliferation of leukemic human B cells.

Authors:  O Lantz; C Grillot-Courvalin; C Schmitt; J P Fermand; J C Brouet
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  4 in total

1.  Impaired mitogen responses of the non-leukaemic B cells from patients with chronic lymphocytic leukaemia.

Authors:  A Morgan; J Eaves; J W Mockford; V Malkovska
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 2.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Demonstration of high-affinity interleukin-2 receptors on B-chronic lymphocytic leukemia cells: functional and structural characterization.

Authors:  H Yagura; T Tamaki; T Furitsu; Y Tomiyama; T Nishiura; N Tominaga; S Katagiri; T Yonezawa; S Tarui
Journal:  Blut       Date:  1990-03

4.  Expression of functional interleukin 2 receptors on chronic lymphocytic leukaemia B lymphocytes is modulated by recombinant interleukin 2.

Authors:  J J Murphy; V Malkovska; L Hudson; R E Millard
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.